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In recent years, the pharmaceutical industry is going through a period of exceptional changes, 
where emerging-market expansion and technology advances have increased sector growth. 
Many new drug candidates found in the drug discovery pipeline generally have poor physico-
chemical and biopharmaceutical properties, such as poor solubility or low chemical 
compatibility, which severly limits their oral bioavailability and thus therapeutic performance. 
The reduction in the numbers of new molecules coming to market along with the expiry of the 
existing patents is also forcing the pharmaceutical industry to invest in and embrace new 
technologies that can save both costs and time for manufacture. One timely solution to the 
growing need can be the exploitation of continuous manufacturing and process engineering 
with better controls, reproducibility, low labour and production cost. Recently, implementation 
of process analytical tools (PAT) under the Quality by Design (QbD) paradigm has attracted a 
strong interest by pharmaceutical scientists as well as the regulatory agencies across the globe. 
The ultimate aims of these QbD approaches are being the science-based design and 
development of formulation and manufacturing processes for the predefined product quality 
objects. 
As the guest editors of this special issue of Drug Delivery and Translational Research, 
we are pleased to introduce our theme issue on“Process Engineering and Pharmaceutical 
Manufacturing Technologies”. This theme issue contains two distinct parts: the first part 
focuses on recent developments of various novel formulations via continuous manufacturing, 
i.e. HME, whereas the second part focuses on various aspects of emerging pharmaceutical 
technologies and and their contributions to drug delivery. Timely and authoritative, this issue 
containing 15 original research articles and 5 critical review articles that will be of significant 
interest to readers across both industry and academia. 
The paper authored by Wesholowski et al., reported the application of an in-line 
UV/Vis spectrometer as a PAT tool for early development of Twin-Screw-Extruder and the 
performance tested in accordance to the ICH Q2 – guideline. In this study, the authors explored 
two APIs (carbamazepine and theophylline) with one polymer matrix (copovidone) to quantify 
the drug loading in the formulation. Similarly, Omar et al., studied the temperature of the 
ribbon via an online thermal camera which was used to explain the differences in ribbon 
properties at varying process parameters. The authors found that the increase in the roller speed 
during roller compaction somehow decreased the width of the ribbon while increasing the 
percentage of fines in the product. In a separate study, Al Asady et al., studied the plastic 
deformation of various primary particles via roller compaction process by determining two 
mechanical properties; the nano-indentation hardness and the viscoelasticity of the primary 
powder. The authors also identified that the plastic deformation of the material had the potential 
to provide an indication for the ability of the primary powder to produce a good ribbon. Desai 
et al, implemented a Design of Experiments (DoE), a tool of Quality by Design (QbD) 
paradigm, in order to evaluate the interaction of input variables (compression force, tablet 
punch configuration and DC filler) affecting the response factors (tablet hardness and capping 
rating) during the manufacture of pharmaceutical tablets. Similarly, Pawar et al., investigated 
the dissolution rate performance of amorphous solid solutions of a poorly water-soluble drug, 
efavirenz (EFV), in amorphous polymeric matrices by adopting a Box-Behnken design of 
experiment (DoE) approach. Box Behnken factorial design was conducted to evaluate the effect 
of independent variables such as polymer ratio, HME screw speed, and processing temperature 
on responses such as solubility, dissolution rate. 
In another study, Majumder et al., explored the first case of the implementation of 
solution calorimetry (SolCal) in order to determine the amorphous content of crystalline drug 
in the amorphous granules prepared via emerging single step continuous twin-screw dry 
granulations (TSG). The authors claimed to have made an attempt to interrelate the findings 
from the SolCal to that of the release of the drug. Li et al, presented a new polymer blend 
system of ethylcellulose (EC) with poly(vinylpyrrolidone-co-vinyl acetate) (PVP VA64) for 
sustained release prepared via HME whereas Sawant et al., explored the use of Eudragit®S100 
and Eudragit®L100 alone or in combination with release-modifying agent namely. PolyoxTM 
WSR 303 and Eudragit®L100-55 for delayed release dosage forms via HME processing.  A 
critical review in the area of sustained release dosage forms authored by Feng et al., provides 
a comprehensive report on the formulation composition and processing conditions of twin-
screw extrusion and how these factors affect the drug release properties of sustained-release 
dosage forms whereas Maincent et al., reviewed the details of the challenges and the 
formulation approaches employed during the manufacture of sustained-release amorphous 
solid dispersions (ASDs). Another review paper authored by Chavan et al., describes various 
continuous manufacturing methods for co-crystal production, along with in-line monitoring 
during cocrystal production, emphasizing on Process Analytical Technology (PAT) as well as 
the scale up issues of continuous and batch co-crystallization and other suitable techniques for 
pharmaceutical scale up. Brunaugh et al., critically discuss the optimization of the 
pharmaceutical milling process through design-space development, theoretical and empirical 
modelling, and monitoring of critical quality attributes. 
Ahmed et al., developed a calcium alginate (CA) wafer dressings by lyophilization of 
hydrogels to deliver ciprofloxacin (CIP) directly to the wound site of infected diabetic foot 
ulcers (DFUs) whereas Molina et al., utilised optimised spray drying process to modify the 
physicochemical/mechanical properties of particles of lactose-based particles to enhance the 
aerosolisation performance of salbutamol sulphate in the presence of leucine in the spray dried 
powders. Trivedi et al., reported a study that considers the in vitro uptake and release 
characteristics of the binary theophylline-smectite system with a maximum uptake of 67 ± 2 
mg g-1. In a separate study, the group developed polycaprolactone (PCL) nanoparticles via 
supercritical fluid extraction of emulsions (SFEE) using supercritical carbon-dioxide (scCO2). 
Jara et al., studied the process to yield monomodal and uniform polymeric nano-particles via 
a nanoprecipitation method. To further identify key variables and their interactions, the authors 
used artificial neural networks (ANN) to investigate the multiple variables which influence the 
process. In another study, Fritz et al., developed a novel lipid-core micelle (LCM) as a 
nanocarrier to encapsulate a poorly water-soluble drug, nifedipine (NFD), by hot-melt 
emulsification, a low-energy method. Haj-Ahmad et al., designed, engineered and utilised a 
novel multi-tip emitter (MTE) devices for potential up-scaled electrohydrodynamic 
atomisation (EHDA) an emerging technique for the production of micron and nano-scaled 
particles of ketoprofen – a model drug, by comparison with a conventional single needle 
system. An exhaustive review paper authored by Tarbox et al., highlights recent developments 
in microneedle coating and manufacturing techniques, including micro-milling, atomized 
spraying, inkjet printing, drawing lithography, droplet-born air blowing, electro-drawing, 
continuous liquid interface production, 3-D printing, and polyelectrolyte multilayers coating.   
The guest editors of this theme issue would also like to thank the authors for their 
valuable contributions and input without which this theme issue would not have been possible. 
It is through their persistent and collective efforts that such a comprehensive and insightful 
theme issue was created. 
 
